Acadia Pharmaceuticals
ACADNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$3.653 B
$21.20 -1.26%
Close of 6 Nov 2026
As of 6 Nov 2026, Acadia Pharmaceuticals (ACAD) has a market capitalization of $3.65B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$1.07B
#1479 by revenue
Earnings
$391.0M
#723 by earnings
Shares outstanding
172,828,972
Latest filing cover page
P/E ratio
9.3
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #60LiquidiaLQDA$3.98B
- #61Xenon PharmaceuticalsXENE$3.66B
- #62Acadia PharmaceuticalsACAD$3.65B
- #63Organon & Co.OGN$3.63B
- #64AbCellera BiologicsABCL$3.60B
What if Acadia Pharmaceuticals were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Acadia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.